Medi Assist Healthcare Services Ltd is Rated Strong Sell

Jan 26 2026 10:10 AM IST
share
Share Via
Medi Assist Healthcare Services Ltd is rated Strong Sell by MarketsMojo. This rating was last updated on 02 Dec 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 26 January 2026, providing investors with the latest perspective on the company’s position.
Medi Assist Healthcare Services Ltd is Rated Strong Sell



Understanding the Current Rating


The Strong Sell rating assigned to Medi Assist Healthcare Services Ltd indicates a cautious stance for investors. It suggests that the stock is expected to underperform relative to the broader market and peers, and investors should consider reducing exposure or avoiding new positions. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.



Quality Assessment


As of 26 January 2026, the company’s quality grade is assessed as average. This reflects a moderate level of operational efficiency and profitability. While Medi Assist maintains a return on equity (ROE) of 14%, which is respectable, it does not stand out strongly against industry benchmarks. The company’s business model and earnings consistency have not demonstrated significant strength to warrant a higher quality grade.



Valuation Perspective


The valuation grade for Medi Assist is very expensive. Currently, the stock trades at a price-to-book (P/B) ratio of 5.4, which is considerably high relative to its peers and historical averages. This elevated valuation suggests that the market has priced in optimistic growth expectations. However, given the company’s recent performance and financial trends, this premium appears unjustified, signalling potential downside risk for investors paying a high price for the stock.



Financial Trend Analysis


The financial grade is very negative, reflecting deteriorating fundamentals. Despite a modest 5% increase in profits over the past year, the stock has delivered a negative return of -27.15% over the same period. This divergence indicates that the market is concerned about the sustainability of earnings growth and the company’s ability to translate profits into shareholder value. Additionally, the stock has underperformed the BSE500 index over the last three years, one year, and three months, highlighting persistent challenges in financial performance.



Technical Outlook


Technically, the stock is graded as bearish. Price action over recent months shows a clear downward trend, with the stock declining by 0.81% in the last trading day and 7.16% over the past month. The three-month and six-month returns stand at -23.15% and -22.79%, respectively, reinforcing the negative momentum. This bearish technical setup suggests limited near-term upside and increased risk of further declines.



Stock Performance Summary


As of 26 January 2026, Medi Assist Healthcare Services Ltd is classified as a smallcap stock within the insurance sector. Its recent price performance has been disappointing, with a year-to-date return of -8.64% and a one-year return of -27.15%. The stock’s underperformance relative to broader market indices and peers underscores the challenges it faces in regaining investor confidence.



Implications for Investors


The Strong Sell rating serves as a cautionary signal for investors. It suggests that the stock currently carries elevated risk due to its expensive valuation, weak financial trends, and negative technical indicators. Investors should carefully consider these factors before initiating or maintaining positions in Medi Assist Healthcare Services Ltd. The rating implies that capital preservation should be prioritised, and alternative investment opportunities with stronger fundamentals and more attractive valuations may be preferable.



Sector and Market Context


Within the insurance sector, Medi Assist’s valuation and performance metrics stand out as less favourable compared to many peers. The company’s high P/B ratio contrasts with its average quality and negative financial trend, indicating a disconnect between price and underlying fundamentals. This misalignment is a key reason for the cautious rating and suggests that the market may be reassessing the company’s growth prospects and risk profile.




Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!



  • - Clear entry/exit targets

  • - Target price revealed

  • - Detailed report available


View Target Price Report →




Conclusion


In summary, Medi Assist Healthcare Services Ltd’s current Strong Sell rating by MarketsMOJO reflects a comprehensive evaluation of its present-day fundamentals and market position as of 26 January 2026. The stock’s average quality, very expensive valuation, very negative financial trend, and bearish technical outlook collectively justify a cautious approach. Investors should weigh these factors carefully and consider the risks before engaging with this stock.


While the company has shown some profit growth, the overall market performance and valuation metrics suggest limited upside potential and heightened downside risk. This rating serves as a guide for investors seeking to manage risk and optimise portfolio performance in the current market environment.



Key Metrics at a Glance (As of 26 January 2026):



  • Mojo Score: 19.0 (Strong Sell)

  • Return on Equity (ROE): 14%

  • Price to Book Value (P/B): 5.4 (Very Expensive)

  • 1-Year Stock Return: -27.15%

  • 6-Month Stock Return: -22.79%

  • 3-Month Stock Return: -23.15%

  • Year-to-Date Return: -8.64%

  • Daily Change: -0.81%



These figures highlight the challenges facing Medi Assist Healthcare Services Ltd and underpin the rationale for the current rating.



About MarketsMOJO Ratings


MarketsMOJO’s rating system integrates multiple dimensions of stock analysis to provide investors with actionable insights. The Strong Sell grade indicates that the stock is expected to underperform and carries significant risk relative to the market. This rating is intended to help investors make informed decisions based on a balanced assessment of quality, valuation, financial trends, and technical factors.



Investors are encouraged to consider these ratings alongside their own research and investment objectives.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News